Rapid Development of Methicillin-Resistant Staphylococcus aureus (MRSA) Purulent Pericarditis in the Setting of Endocarditis

Authors

Samiullah Arshad, University of KentuckyFollow
Naoki Misumida, University of KentuckyFollow

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) purulent pericarditis is a rare but potentially fatal complication of MRSA bacteremia. We describe a case of a 27-year-old patient with active intravenous drug use, who presented with fever, chills, and dyspnea and was found to have tricuspid valve endocarditis. Echocardiogram on admission showed no pericardial effusion. The patient became hypotensive, with worsening dyspnea, in the following 3 days. A computed tomography scan of the chest was repeated and showed a large pericardial effusion. The patient underwent pericardiocentesis and pericardial drain placement. Antibiotics were continued, with resolution of effusion. Early pericardiocentesis of a large purulent pericardial effusion may prevent catastrophic outcomes.

Document Type

Article

Publication Date

7-14-2021

Notes/Citation Information

Published in CJC Open, v. 3, issue 12.

© 2021 The Authors

This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).

Digital Object Identifier (DOI)

https://doi.org/10.1016/j.cjco.2021.06.020

Repository Citation

Arshad, Samiullah and Misumida, Naoki, "Rapid Development of Methicillin-Resistant Staphylococcus aureus (MRSA) Purulent Pericarditis in the Setting of Endocarditis" (2021). Internal Medicine Faculty Publications. 273.
https://uknowledge.uky.edu/internalmedicine_facpub/273